APA (7th ed.) Citation

Letsa, I., Mikropoulos, C., Burcombe, R., Visioli, A., Sevitt, T., Cominos, M., & Beesley, S. (2011). 19 A Kent and Medway Cancer Network (KMCN) audit of first-line treatment with cisplatin/pemetrexed (CisPem) in non squamous non-small cell lung cancer (NSCLC). Lung Cancer (01695002), 71, S7. https://doi.org/10.1016/S0169-5002(11)70019-8

Chicago Style (17th ed.) Citation

Letsa, I., C. Mikropoulos, R. Burcombe, A. Visioli, T. Sevitt, M. Cominos, and S. Beesley. "19 A Kent and Medway Cancer Network (KMCN) Audit of First-line Treatment with Cisplatin/pemetrexed (CisPem) in Non Squamous Non-small Cell Lung Cancer (NSCLC)." Lung Cancer (01695002) 71 (2011): S7. https://doi.org/10.1016/S0169-5002(11)70019-8.

MLA (9th ed.) Citation

Letsa, I., et al. "19 A Kent and Medway Cancer Network (KMCN) Audit of First-line Treatment with Cisplatin/pemetrexed (CisPem) in Non Squamous Non-small Cell Lung Cancer (NSCLC)." Lung Cancer (01695002), vol. 71, 2011, p. S7, https://doi.org/10.1016/S0169-5002(11)70019-8.